logo

For the Inventor, By the Inventor

King of Prussia, PA, United States of America

Philip C Dell'Orco

This inventor holds 8 USPTO granted patents. Top assignees: Smithkline Beecham (Cork) Ltd, Glaxosmithkline LLC, Sb Pharmco Puerto Rico Inc.. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip C Dell'Orco. Retrieved from https://idiyas.com/inventor/philip-c-dell-orco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 30(Granted Patents)


Company Filing History:

goldMedal3 out of 10 
 
Smithkline Beecham (Cork) Ltd
 patents
silverMedal2 out of 358 
 
Glaxosmithkline LLC
 patents
bronzeMedal2 out of 6 
 
Sb Pharmco Puerto Rico Inc.
 patents
4. 1 out of 1 
 
Smithkline Beechman Cork Limited
 patent

Years Active: 2009-2012

Loading Chart...
8 patents (USPTO):Explore Patents
1. 8158645 - Compound, corresponding compositions, preparation and/or treatment methods (2012-04-17),
2. 7902378 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2011-03-08),
3. 7893100 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2011-02-22),
4. 7759384 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2010-07-20),
5. 7754733 - Crystalline topotecan hydrochloride product and process for making the same (2010-07-13),
6. 7750036 - Carvedilol salts, corresponding compositions, methods of delivery and/or treatment (2010-07-06),
7. 7649010 - Carvedilol hydrobromide (2010-01-19),
8. 7626041 - Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment (2009-12-01),

Title: The Innovations of Philip C Dell'Orco

Introduction

Philip C Dell'Orco is a notable inventor based in King of Prussia, PA (US). He holds a total of 8 patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on novel compounds and methods for treating various diseases, including cancer and hypertension.

Latest Patents

Dell'Orco's latest patents include a groundbreaking crystalline form of topotecan monohydrochloride pentahydrate. This compound is designed to treat anti-viral and cancer-related diseases. Another significant patent involves carvedilol phosphate salts, which are used to treat hypertension, congestive heart failure, and angina. These inventions highlight his commitment to advancing medical treatments through innovative pharmaceutical compositions.

Career Highlights

Throughout his career, Dell'Orco has worked with prominent companies such as SmithKline Beecham Ltd and Sb Pharmco Puerto Rico Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of medical science.

Collaborations

Dell'Orco has collaborated with notable professionals in his field, including Lee M Katrincic and Christopher S Brook. These partnerships have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Philip C Dell'Orco's contributions to pharmaceutical innovation are significant and noteworthy. His patents reflect a dedication to improving healthcare through advanced treatments. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…